Page last updated: 2024-09-05

sorafenib and GDC-0879

sorafenib has been researched along with GDC-0879 in 4 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(GDC-0879)
Trials
(GDC-0879)
Recent Studies (post-2010) (GDC-0879)
6,5207305,2511009

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)GDC-0879 (IC50)
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.2003
Mitogen-activated protein kinase 3 Homo sapiens (human)0.063
Mitogen-activated protein kinase 1Homo sapiens (human)0.063

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandhuber, BJ; Buckmelter, AJ; Callejo, M; Grina, J; Laird, ER; Lyssikatos, J; Martinson, M; Miknis, G; Morales, T; Randolph, N; Rast, B; Ren, L; Schlachter, S; Tarlton, E; Vigers, G; Welch, M; Wenglowsky, S1
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP1
Kim, J; Wang, X1
Agianian, B; Gavathiotis, E1

Reviews

1 review(s) available for sorafenib and GDC-0879

ArticleYear
Current Insights of BRAF Inhibitors in Cancer.
    Journal of medicinal chemistry, 2018, 07-26, Volume: 61, Issue:14

    Topics: Animals; Drug Discovery; Humans; Mutation; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf

2018

Other Studies

3 other study(ies) available for sorafenib and GDC-0879

ArticleYear
The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors.
    Bioorganic & medicinal chemistry letters, 2011, Feb-15, Volume: 21, Issue:4

    Topics: Animals; Binding Sites; Cell Line, Tumor; Computer Simulation; Drug Evaluation, Preclinical; Humans; Indans; Microsomes, Liver; Models, Chemical; Models, Molecular; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridines; Rats; Structure-Activity Relationship

2011
Comprehensive analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11

    Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity

2011
Conformation-specific effects of Raf kinase inhibitors.
    Journal of medicinal chemistry, 2012, Sep-13, Volume: 55, Issue:17

    Topics: Dimerization; Models, Molecular; Protein Conformation; Protein Kinase Inhibitors; raf Kinases

2012